Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Bausch & Lomb Corp
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"BAUSCH + LOMB CORPORATION $1,400,000,000 8.375% SENIOR SECURED NOTES DUE 2028 INDENTURE DATED AS OF SEPTEMBER 29, 2023",
"Credit Agreement, as amended by the First Incremental Amendment, by and among Bausch + Lomb Corporation, certain subsidiaries of Bausch + Lomb Corporation as subsidiary guarantors, the lenders party thereto, Citibank, N.A., as collateral agent thereto, Goldman Sachs Bank USA, as term facility administrative agent thereto and JPMorgan Chase Bank, N.A., as first incremental term facility administrative agent thereto",
"Bausch + Lomb Completes Acquisition of XIIDRA ®" |
|
| 08/02/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/02/2023 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
8-K
| Quarterly results |
| 07/27/2023 |
4
| Munsch Frederick (SVP, Controller and CAO) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Paid exercise price by delivering 1,313 shares
@ $19.82, valued at
$26k
|
|
| 07/27/2023 |
4
| Hashad Yehia (EVP of R&D and CMO) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Paid exercise price by delivering 3,996 shares
@ $19.82, valued at
$79.2k
|
|
| 07/27/2023 |
4
| Bonnefoy Luc (President, Surgical) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Paid exercise price by delivering 2,240 shares
@ $19.82, valued at
$44.4k
|
|
| 07/27/2023 |
4
| Eldessouky Sam (EVP and CFO) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Paid exercise price by delivering 4,218 shares
@ $19.82, valued at
$83.6k
|
|
| 07/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 07/05/2023 |
4
| ROBERTSON RUSSEL C (Director) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 1,276 shares
@ $20.07, valued at
$25.6k
|
|
| 07/05/2023 |
4
| Paulson John (Director) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 1,089 shares
@ $20.07, valued at
$21.9k
|
|
| 07/05/2023 |
4
| DE SCHUTTER RICHARD U (Director) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 1,339 shares
@ $20.07, valued at
$26.9k
|
|
| 07/05/2023 |
4
| Bernier Nathalie D. (Director) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 1,245 shares
@ $20.07, valued at
$25k
|
|
| 06/30/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 06/16/2023 |
4
| Bonnefoy Luc (President,Surgical) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 5,361 shares
@ $0 |
|
| 06/12/2023 |
3
| Bonnefoy Luc (President,Surgical) has filed a Form 3 on Bausch & Lomb Corp |
| 06/01/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Bausch + Lomb Announces Key Leadership Changes VAUGHAN, Ontario, June 1, 2023 – Bausch + Lomb Corporation , a leading global eye health company dedicated to helping people see better to live better, announced a reshaping of its executive leadership team, including the elevation of all business unit heads. Luc Bonnefoy, senior vice president , Surgical; John Ferris, SVP, Consumer; and Yang Yang, SVP, Vision Care; will join the executive management team of the Company reporting directly to Brent Saunders, chairman and CEO. Concurrent with this change, Joseph Gordon, president, Global Consumer, Surgical and Vision Care, will transition to the role of Strategic Advisor to Saunders. Additionally, Louis Yu, Ph.D., executive vice president and Chief Quality Officer, has notified Bausch + Lomb of ..." |
|
| 05/05/2023 |
4
| Bailey A Robert D (EVP & Chief Legal Officer) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 429,184 options to buy
@ $17.5, valued at
$7.5M
|
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| ROBERTSON RUSSEL C (Director) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 12,857 shares
@ $0 |
|
| 05/05/2023 |
4
| Paulson John (Director) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 12,857 shares
@ $0 |
|
| 05/05/2023 |
4
| KAVANAGH SARAH B (Director) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 12,857 shares
@ $0 |
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| Hu Gaoxiang (Director) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 12,857 shares
@ $0 |
|
| 05/05/2023 |
4
| DE SCHUTTER RICHARD U (Director) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 12,857 shares
@ $0 |
|
| 05/05/2023 |
4
| Bernier Nathalie D. (Director) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 12,857 shares
@ $0 |
|
| 05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/03/2023 |
8-K
| Quarterly results |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/26/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|
|